Clinical value of fecal calprotectin

Volume: 56, Issue: 5, Pages: 307 - 320
Published: Jun 6, 2019
Abstract
Inflammatory bowel disease (IBD) denotes a group of chronic incurable disorders characterized by relapsing-remitting inflammation of the gastrointestinal tract. IBD represents a growing global burden with a prevalence exceeding 0.3% in the Western world and an accelerating incidence in newly industrialized countries. The target for treating IBD has shifted in recent years from symptom control to mucosal healing (MH), which has been shown to be...
Paper Details
Title
Clinical value of fecal calprotectin
Published Date
Jun 6, 2019
Volume
56
Issue
5
Pages
307 - 320
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.